Clinical Laboratory Services Market is projected to reach USD 282960 million by 2028, from USD 192650 million in 2021, at a CAGR of 5.2% during 2022-2028.
Major Factors Driving the Growth of Clinical Laboratory Services Market
The clinical laboratory services market is primarily driven by the increase in patients’ chronic diseases and the increased demand for early diagnostic testing. The need for individualized treatment and rising consumer awareness of the importance of routine lab tests for maintaining vital signs are projected to drive the market for clinical laboratory services.
During the forecast period, it is also anticipated that quick technology advances to boost productivity and save costs will boost the clinical laboratory services market
Get Your Sample Today:
TRENDS INFLUENCING THE GROWTH OF THE CLINICAL LABORATORY SERVICES MARKET
Clinical laboratory services are becoming more and more crucial to the modern healthcare system. From early disease detection and diagnosis to customized treatment plans based on each patient’s individual genetic profile, clinical lab testing is essential to enhancing patient care and lowering long-term healthcare costs. This factor is expected to drive the growth of the Clinical Laboratory Services market.
Additionally, it is anticipated that rising public awareness of the need of preserving health and undergo regular exams would further drive the Clinical Laboratory Services market. Regular vitals are tested on patients using clinical chemistry. Blood and urine are the most typical specimens utilized in clinical chemistry. To find and measure practically every type of chemical component in blood or urine, there are numerous different assays available.
It is anticipated that the rising demand for early cancer screening as a result of the rising incidence of cancer would serve as a significant growth driver for both human and tumor genetics. This factor is expected to drive the growth of the Clinical Laboratory Services Market.
Clinical Laboratory is central to all facets of personalized medicine. Test findings are used to maintain health, diagnose sickness, forecast and monitor treatment response, and stratify people for comparative effectiveness studies, from the most fundamental traditional biomarkers to those just discovered. This element is anticipated to further fuel the market’s expansion for clinical laboratory services.
Clinical Laboratory Services frequently puts laboratory technology at the forefront. Before receiving successful therapy, there are occasionally diagnostic methods available to identify or screen for a certain ailment. Testing has become more efficient and automated thanks to advancements in laboratory technology, which include both novel tests and improvements to tools and testing procedures.
Browse The Table Of Contents And List Of Figures At:
CLINICAL LABORATORY SERVICES MARKET SHARE ANALYSIS:
Based on test type, the clinical chemistry segment is expected to be the most lucrative segment. This is due to the development of point-of-care testing techniques, the use of multiple clinic chemistry assays, and the introduction of new technology. Additionally, the expanding investments made by healthcare industry players in research activities are promoting the development of laboratories around the world. As a result, this category is anticipated to grow at the quickest rate during the projected period.
Based on application, the hospital-based laboratories segment is expected to be the most lucrative. The growth of this market over the past several years has been aided by factors such as the rising incidence of cancer in the general population, the expansion of research projects aimed at creating novel services, and the rising need for clinical chemistry services in hospitals.
Based on region, North America is the most lucrative region in the market for clinical laboratory services. Due to growing awareness and the high prevalence of chronic diseases in the nation, which depend on clinical laboratory services for effective patient care, it is predicted that the U.S. will experience significant growth.
Get Regional Data:
Key Companies:
Quest Diagnostics
Laboratory Corporation Of America Holdings (LabCorp)
Abbott
Charles River Laboratories
Siemens Healthineers
OPKO Health Inc
ARUP Laboratories
Sonic Healthcare
Neogenomics Laboratories, Inc
Inquire for Chapter Cost:
Buy Now for Single User + Covid-19 Impact :
SUBSCRIPTION
We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.
SIMILAR REPORTS:
- Clinical Microbiology market size is projected to reach USD 4081.4 million by 2028, from USD 3171.1 million in 2021, at a CAGR of 3.6% during 2022-2028.
- Cell culture market accounted for USD 16,107.7 million in 2019 and is expected to reach USD 36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.
- Preclinical CRO market size is projected to reach USD 4880.9 million by 2028, from USD 3452.8 million in 2021, at a CAGR of 4.6% during 2022-2028.
- Clinical Chemistry Analyzer market size is estimated to be worth USD 9897.3 million in 2022 and is forecast to be a readjusted size of USD 11900 million by 2028 with a CAGR of 3.1% during the review period.
- Clinical Laboratory Tests market size is projected to reach USD 417990 million by 2028, from USD 267670 million in 2021, at a CAGR of 6.5% during 2022-2028.
- Pharmaceutical Aseptic Fill & Finish CMO market size is projected to reach USD 4788.5 million by 2028, from USD 2229.7 million in 2021, at a CAGR of 11.4% during 2022-2028.
- Biological Safety Cabinet market size is estimated to be worth USD 213.6 million in 2022 and is forecast to be a readjusted size of USD 331.4 million by 2028 with a CAGR of 7.6% during the review period.
- Laboratory Chemicals market size is estimated to be worth USD 23590 million in 2022 and is forecast to be a readjusted size of USD 33850 million by 2028 with a CAGR of 6.2% during the review period.
- Laboratory Plastic Ware market size is estimated to be worth USD 6081.3 million in 2022 and is forecast to a readjusted size of USD 8665.6 million by 2028 with a CAGR of 6.1%.
- Cleanroom Consumables Market was valued at USD 3688.38 million in 2020, and it is anticipated to reach USD 6658.35 million by 2030, registering a CAGR of about 5.40% during the forecast period (2021 to 2030).
- Global Preclinical Magnetic Resonance Imaging (MRI) Market Insights, Forecast to 2028
- Global Medical Practice Management Platform Market Research Report 2022
- Global Human Reference Laboratory Market Research Report 2022
- Global Clinical Laboratory Test Sales Market Report 2022
- Global Healthcare and Laboratory Labels Market Insights and Forecast to 2028
- Global Clinical Research Software Market Insights, Forecast to 2028
- Global Clinical Immunoanalyzer Sales Market Report 2022
- Global Clinical Thermometer Sales Market Report 2022
- Global Blood Test Results Analysis Software Market Research Report 2022
- Global Physical Examination Sales Market Report 2022
- Healthcare Analytics market size was valued at USD 23.51 billion in 2020 and is projected to reach USD 96.90 billion by 2030, growing at a CAGR of 15.3% from 2021 to 2030.
- Healthcare Information technology (IT) market size was valued at USD 250,577.15 million in 2020 and is projected to reach USD 880,688.75 million by 2030, registering a CAGR of 13.3% from 2021 to 2030.
- The global Genome Editing market size is projected to reach USD 6739.8 Million by 2028, from USD 3513 Million in 2021, at a CAGR of 9.3% during 2022-2028.
- Due to the COVID-19 pandemic, the global Organ-on-a-Chip market size is estimated to be worth USD 80 Million in 2022 and is forecast to a readjusted size of USD 581.2 Million by 2028 with a CAGR of 39.1% during the review period.
- The Global Bioinformatics Market Size is USD 8,614.29 Million in 2019, and is projected to reach USD 24,731.61 Million by 2027, growing at a CAGR of 13.4% from 2020 to 2027.
